Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (17)

2023

  1. Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus document

    Radiologia, Vol. 65, Núm. 3, pp. 269-284

  2. Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus document

    Revista Espanola de Cardiologia, Vol. 76, Núm. 3, pp. 183-196

2021

  1. COPD Clinical Control: predictors and long-term follow-up of the CHAIN cohort

    Respiratory research, Vol. 22, Núm. 1, pp. 36

  2. Circulating levels of the interferon-γ-regulated chemokines cxcl10/cxcl11, il-6 and hgf predict outcome in metastatic renal cell carcinoma patients treated with antiangiogenic therapy

    Cancers, Vol. 13, Núm. 11

  3. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex

    Chest, Vol. 160, Núm. 2, pp. 481-490

  4. Pazopanib as Second-line Antiangiogenic Treatment in Metastatic Renal Cell Carcinoma After Tyrosine Kinase Inhibitor (TKI) Failure: A Phase 2 Trial Exploring Immune-related Biomarkers for Testing in the Post-immunotherapy/TKI Era

    European urology oncology, Vol. 4, Núm. 3, pp. 502-505

2020

  1. A delphi consensus document on the use of single-inhaler fixed-dose triple therapies in copd patients

    International Journal of COPD, Vol. 15, pp. 1801-1811

2018

  1. Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort

    Chest, Vol. 154, Núm. 2, pp. 274-285

2016

  1. Defining the asthma-COPD overlap syndrome in a COPD Cohort

    Chest, Vol. 149, Núm. 1, pp. 45-52

  2. Distribution and outcomes of a phenotype-based approach to guide COPD management: Results from the CHAIN cohort

    PLoS ONE, Vol. 11, Núm. 9

2015

  1. Differential effect of modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPD

    Chest, Vol. 148, Núm. 1, pp. 159-168

  2. What pulmonologists think about the asthma–COPD overlap syndrome

    International Journal of COPD, Vol. 10, pp. 1321-1330

2014

  1. Clinical application of the COPD assessment test: Longitudinal data from the COPD history assessment in Spain (CHAIN) Cohort

    Chest, Vol. 146, Núm. 1, pp. 111-122

  2. Erratum: New GOLD classification: Longitudinal data on group assignment [Respir Res. 15, (2014) 3, 10.1186/1465-9921-15-3]

    Respiratory Research

  3. Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma

    PLoS ONE, Vol. 9, Núm. 1

  4. New GOLD classification: Longitudinal data on group assignment

    Respiratory Research, Vol. 15, Núm. 1

2011

  1. Phase II study of sunitinib as first-line treatment of urothelial cancer patients ineligible to receive cisplatin-based chemotherapy: Baseline interleukin-8 and tumor contrast enhancement as potential predictive factors of activity

    Annals of Oncology, Vol. 22, Núm. 12, pp. 2646-2653